ES2570310T3 - Composiciones para la vacunación por vía cutánea - Google Patents
Composiciones para la vacunación por vía cutáneaInfo
- Publication number
- ES2570310T3 ES2570310T3 ES08864603T ES08864603T ES2570310T3 ES 2570310 T3 ES2570310 T3 ES 2570310T3 ES 08864603 T ES08864603 T ES 08864603T ES 08864603 T ES08864603 T ES 08864603T ES 2570310 T3 ES2570310 T3 ES 2570310T3
- Authority
- ES
- Spain
- Prior art keywords
- skin
- vaccine formulation
- mammal
- dry
- adjuvant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 238000002255 vaccination Methods 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 abstract 4
- 229960005486 vaccine Drugs 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Surgical Instruments (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Utilización de una formulación de vacuna para la preparación de una composición para la vacunación epicutánea de un mamífero, preferentemente un humano, caracterizada por que la formulación de vacuna está en forma seca y desprovista de adyuvante, y por que se administra por aplicación sobre la piel intacta del mamífero por medio de un dispositivo cutáneo que forma en contacto con la piel un compartimento de condensación que posee un volumen comprendido entre 1 y 300 mm3/cm2 de superficie del dispositivo, conteniendo dicho dispositivo una cantidad de formulación de vacuna comprendida entre 0,1 μg y 500 μg por cm2 de superficie, manteniéndose el dispositivo sobre la piel durante un periodo de 6 a 72 horas, e induciendo dicha aplicación de la formulación en forma seca y desprovista de adyuvante sobre la piel intacta una respuesta inmune específica de antígeno caracterizada por la producción de anticuerpos del tipo IgG.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0759505A FR2924350B1 (fr) | 2007-12-03 | 2007-12-03 | Procede et compositions pour la vaccination par voie cutanee |
PCT/FR2008/052198 WO2009080933A1 (fr) | 2007-12-03 | 2008-12-03 | Procede et compositions pour la vaccination par voie cutanee |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2570310T3 true ES2570310T3 (es) | 2016-05-17 |
Family
ID=39537456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES08864603T Active ES2570310T3 (es) | 2007-12-03 | 2008-12-03 | Composiciones para la vacunación por vía cutánea |
Country Status (10)
Country | Link |
---|---|
US (1) | US8968743B2 (es) |
EP (1) | EP2217222B1 (es) |
JP (1) | JP6017111B2 (es) |
KR (1) | KR101605694B1 (es) |
CN (2) | CN104721815A (es) |
CA (1) | CA2706363C (es) |
ES (1) | ES2570310T3 (es) |
FR (1) | FR2924350B1 (es) |
IL (1) | IL205821A (es) |
WO (1) | WO2009080933A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2924349B1 (fr) | 2007-12-03 | 2010-01-01 | Dbv Tech | Methode de desensibilitation aux allergenes |
FR2926466B1 (fr) * | 2008-01-23 | 2010-11-12 | Dbv Tech | Procede de fabrication de patchs par electrospray |
AU2010291171B2 (en) | 2009-09-07 | 2015-10-29 | Dbv Technologies | Method of treating eosinophilic esophagitis |
JP6153863B2 (ja) * | 2010-04-16 | 2017-06-28 | デベヴェ テクノロジーズDbv Technologies | ワクチン接種方法 |
KR102505842B1 (ko) * | 2016-12-30 | 2023-03-03 | 유로메드 인코포레이티드 | 개선된 이형 라이너 시스템을 함유하는 접착 패치 |
US11938178B2 (en) | 2018-07-09 | 2024-03-26 | Dbv Technologies | Optimized epicutaneous vaccination |
CN112869865B (zh) * | 2021-01-11 | 2022-09-02 | 贵阳德漫多医疗科技有限公司 | 一种皮肤热剥脱装置 |
EP4201383A1 (en) | 2021-12-21 | 2023-06-28 | DBV Technologies | Improved patches and methods for delivering an active substance to the skin using the same |
WO2023066846A1 (en) | 2021-10-18 | 2023-04-27 | Dbv Technologies | Improved patches and methods for delivering an active substance to the skin using the same |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB501873A (en) | 1937-04-20 | 1939-03-07 | Hermann Vollmer | New or improved means for carrying out medical tests |
US3212495A (en) * | 1962-06-22 | 1965-10-19 | Hazleton Lab Inc | Sensitivity test patches |
BE642548A (es) | 1963-01-19 | 1964-05-14 | ||
SE337223B (es) * | 1967-05-23 | 1971-08-02 | Pharmacia Ab | |
US3837340A (en) * | 1971-10-20 | 1974-09-24 | Lilly Co Eli | Device for administering immunication against virus |
US3894531A (en) * | 1974-04-12 | 1975-07-15 | Jr Milton A Saunders | Skin patch test device with peelable label |
US4450844A (en) * | 1981-11-23 | 1984-05-29 | Hill Top Research, Inc. | Patch system for use on the skin |
US4435180A (en) * | 1982-05-25 | 1984-03-06 | Alza Corporation | Elastomeric active agent delivery system and method of use |
AU590711B2 (en) * | 1982-10-13 | 1989-11-16 | Biowhittaker, Inc. | Stable allergenic extracts and methods |
SE443914B (sv) * | 1984-10-01 | 1986-03-17 | Torkel Ingemar Fischer | Medel for en overkenslighetstest |
US4743249A (en) * | 1986-02-14 | 1988-05-10 | Ciba-Geigy Corp. | Dermal and transdermal patches having a discontinuous pattern adhesive layer |
US4781705A (en) * | 1987-06-16 | 1988-11-01 | Zyton Inc. | Mineral applicator |
US4788971A (en) * | 1987-07-13 | 1988-12-06 | Hill Top Research, Inc. | Patch system for use on the skin |
US4821733A (en) * | 1987-08-18 | 1989-04-18 | Dermal Systems International | Transdermal detection system |
US5438984A (en) * | 1988-09-08 | 1995-08-08 | Sudor Partners | Apparatus and method for the collection of analytes on a dermal patch |
US5037587A (en) | 1989-07-17 | 1991-08-06 | Mitsui Toatsu Chemicals, Inc. | Preparation process of polyimide film |
US5236455A (en) * | 1992-02-10 | 1993-08-17 | Wilk Peter J | Tympanic patch, applicator, and related method |
JPH06238008A (ja) | 1993-02-15 | 1994-08-30 | Yuutoku Yakuhin Kogyo Kk | パッチテスト用具 |
WO1996032142A1 (en) | 1995-04-12 | 1996-10-17 | Hopp Robert B | Skin patch for use in contact immunotherapy |
US6093419A (en) * | 1995-06-07 | 2000-07-25 | Lectec Corporation | Compliance verification method and device in compulsory drug administration |
US5827530A (en) | 1996-02-05 | 1998-10-27 | Reed, Jr.; Fred Dewitt | Fillable patch for dermal or transdermal delivery |
US5827608A (en) | 1996-10-28 | 1998-10-27 | Minnesota Mining And Manufacturing Company | Method of forming a thermoplastic layer on a flexible two-dimensional substrate and powder for preparing same |
US20060002949A1 (en) * | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
DE29621365U1 (de) | 1996-12-11 | 1997-02-27 | Lohmann Gmbh & Co Kg, 56567 Neuwied | Epikutan-Testpflaster |
US5827068A (en) * | 1996-12-31 | 1998-10-27 | Michelson Packaging Co. | Fruit packaging tray usable with a denesting apparatus |
US6210705B1 (en) * | 1997-12-15 | 2001-04-03 | Noven Pharmaceuticals, Nc. | Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
US20020102291A1 (en) * | 1997-12-15 | 2002-08-01 | Noven Pharmaceuticals, Inc. | Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
EP1356823B1 (en) | 1998-02-25 | 2013-01-02 | THE GOVERNMENT OF THE UNITED STATES, as represented by THE SECRETARY OF THE ARMY | Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response induced by an adjuvant |
FR2781670B1 (fr) | 1998-07-30 | 2001-09-07 | Oreal | Patch cosmetique ou pharmaceutique et son conditionnement |
JP2987702B1 (ja) | 1998-09-07 | 1999-12-06 | 岩手新浄農業協同組合 | 粉末青果物の製造方法 |
US6159497A (en) | 1998-10-30 | 2000-12-12 | Noven Pharmaceuticals, Inc. | Patch applicator |
IL144380A0 (en) | 1999-01-22 | 2002-05-23 | Powderject Res Ltd | Method of enhancing needleless transdermal powdered drug delivery |
ES2173678T3 (es) | 1999-01-27 | 2002-10-16 | Idea Ag | Vacunacion no invasiva a traves de la piel. |
AU4188100A (en) * | 1999-04-08 | 2000-11-14 | Gregory M. Glenn | Dry formulation for transcutaneous immunization |
US6316598B1 (en) * | 1999-09-13 | 2001-11-13 | Keraplast Technologies, Ltd. | Water absorbent keratin and gel formed therefrom |
AU784597B2 (en) | 2000-01-06 | 2006-05-11 | Marantech Holding, Llc | Methods of using electron active compounds for managing cancer |
AU2001231154A1 (en) * | 2000-01-24 | 2001-07-31 | Adherex Technologies Inc. | Peptidomimetic modulators of cell adhesion |
WO2002018544A2 (en) * | 2000-08-31 | 2002-03-07 | Loyola University Chicago | Method and reagents for treatment of skin disorders by modulating the notch pathway |
KR100818545B1 (ko) | 2000-10-13 | 2008-04-01 | 알자 코포레이션 | 마이크로블레이드 어레이 충격 어플리케이터 |
WO2002076379A2 (en) | 2000-11-16 | 2002-10-03 | Chris Lipper | Medicated tattoos |
US7527802B2 (en) * | 2001-02-13 | 2009-05-05 | The United States Of America As Represented By The Secretary Of The Army | Vaccine for transcutaneous immunization |
US7635488B2 (en) * | 2001-03-13 | 2009-12-22 | Dbv Technologies | Patches and uses thereof |
FR2822049B1 (fr) * | 2001-03-13 | 2003-08-01 | Dbv Medica 1 | Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation |
EP1381381A1 (en) | 2001-03-19 | 2004-01-21 | Gregory M. Glenn | Patch for transcutaneous immunization |
JP4339598B2 (ja) | 2001-05-23 | 2009-10-07 | デュオトール アーベー | 毒素サブユニットまたはそのフラグメントと共に、又はこれとコンジュゲートされたアレルゲンの経皮投与によるアレルギー反応の抑制 |
CN1578647B (zh) * | 2001-08-29 | 2010-04-07 | 里卡多·A·P·德卡瓦尔霍 | 一种用于单向传送药剂到目标组织的可以手术植入的及可密封的装置 |
US20040137004A1 (en) * | 2002-03-19 | 2004-07-15 | Glenn Gregory M | Patch for transcutaneous immunization |
DK1545605T3 (da) * | 2002-10-02 | 2010-04-12 | Nordic Vaccine As | Komposition til vaccination |
US20060147509A1 (en) * | 2002-10-02 | 2006-07-06 | Kirkby Nikolai S | Composition for vaccination |
US20040111071A1 (en) | 2002-12-09 | 2004-06-10 | Jeffrey Lewis Powers | Portable device for dispensing hand treatments |
FR2866553B1 (fr) | 2004-02-19 | 2006-06-09 | Dbv Tech | Nouveau type de patch |
US20090017056A1 (en) | 2004-06-15 | 2009-01-15 | Iomai Corporation | Skin immunization using lt-sta fusion proteins |
JP5186678B2 (ja) * | 2005-10-13 | 2013-04-17 | 財団法人ヒューマンサイエンス振興財団 | 経皮抗原投与のための抗原キット |
-
2007
- 2007-12-03 FR FR0759505A patent/FR2924350B1/fr active Active
-
2008
- 2008-12-03 CA CA2706363A patent/CA2706363C/fr active Active
- 2008-12-03 ES ES08864603T patent/ES2570310T3/es active Active
- 2008-12-03 US US12/745,673 patent/US8968743B2/en active Active
- 2008-12-03 KR KR1020107011702A patent/KR101605694B1/ko active IP Right Grant
- 2008-12-03 WO PCT/FR2008/052198 patent/WO2009080933A1/fr active Application Filing
- 2008-12-03 CN CN201510087956.4A patent/CN104721815A/zh active Pending
- 2008-12-03 EP EP08864603.9A patent/EP2217222B1/fr active Active
- 2008-12-03 CN CN2008801188650A patent/CN101883560A/zh active Pending
- 2008-12-03 JP JP2010536516A patent/JP6017111B2/ja active Active
-
2010
- 2010-05-17 IL IL205821A patent/IL205821A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
IL205821A0 (en) | 2010-11-30 |
IL205821A (en) | 2017-03-30 |
AU2008339832A1 (en) | 2009-07-02 |
KR101605694B1 (ko) | 2016-03-24 |
US20100310596A1 (en) | 2010-12-09 |
CA2706363C (fr) | 2016-09-13 |
CN101883560A (zh) | 2010-11-10 |
EP2217222A1 (fr) | 2010-08-18 |
CN104721815A (zh) | 2015-06-24 |
KR20100093536A (ko) | 2010-08-25 |
WO2009080933A1 (fr) | 2009-07-02 |
US8968743B2 (en) | 2015-03-03 |
JP2011505412A (ja) | 2011-02-24 |
EP2217222B1 (fr) | 2016-02-17 |
FR2924350B1 (fr) | 2010-08-13 |
JP6017111B2 (ja) | 2016-10-26 |
CA2706363A1 (fr) | 2009-07-02 |
FR2924350A1 (fr) | 2009-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2570310T3 (es) | Composiciones para la vacunación por vía cutánea | |
ME01199B (me) | Nove kompozicije adjuvanta | |
EA201390631A1 (ru) | Композиция микобактериальных антигенов | |
PE20140173A1 (es) | Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis | |
MX2010001054A (es) | Composiciones adyuvantes antigenicas y metodos. | |
EA201070200A1 (ru) | Композиции, содержащие пневмококковые антигены | |
PE20120319A1 (es) | Composiciones adyuvantes que comprenden un agente de isotonicidad no ionico | |
HN2011001195A (es) | Compuestos que expanden las celulas madre hematopoieticas | |
AR060565A1 (es) | Vacuna para la gripe aviaria y metodos de uso | |
MY150706A (en) | Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant | |
NZ718108A (en) | Neisseria meningitidis compositions and methods thereof | |
CO6321162A2 (es) | Una vacuna que comprende una cantidad inmunogenica de un antigeno en somastatina y un adyuvante | |
WO2008054535A3 (en) | Novel influenza m2 vaccines | |
CO6561819A2 (es) | Vectores para vacunas y método para potenciar respuestas inmunes | |
CU20140145A7 (es) | Vacuna de proteína quimérica contra la neumonía causada por streptococcus pneumoniae | |
CL2011002994A1 (es) | Construccion de proteina que comprende polipeptido casb7439; composicion inmunogenica que comprende dicha construccion; uso de la composicion porque sirve para inducir respuesta inmunitaria al casb7439 en un animal. | |
BRPI0606614A2 (pt) | peptìdeos para distribuição de vacinas na mucosa | |
WO2008133651A3 (en) | Ablative immunotherapy | |
BR112014026407A2 (pt) | formulação de vacina líquida | |
EP2421529A4 (en) | SUNSHORE-CONJUGATED IMMUNOGENIC COMPOSITIONS AND VACCINES | |
MX348137B (es) | Vacuna de la leishmaniasis con el uso del inmunogeno salival de la mosca de la arena. | |
ATE503491T1 (de) | Verbesserte anthraximpfstoffe und abgabeverfahren | |
TW200833709A (en) | Archaeal polar lipid aggregates for administration to animals | |
AR114139A1 (es) | Nano-partículas que contienen variantes sintéticas del gangliósido gm3 como adyuvantes en vacunas | |
AR059648A1 (es) | Antigenos vacunales quimericos contra el virus de la peste porcina clasica |